P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Հիմնական հեղինակներ: | Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
Wiley
2023-08-01
|
Շարք: | HemaSphere |
Առցանց հասանելիություն: | http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2 |
Նմանատիպ նյութեր
-
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
: Sikander Ailawadhi, և այլն
Հրապարակվել է: (2024-11-01) -
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
: Hans C. Lee, և այլն
Հրապարակվել է: (2021-07-01) -
Connect MM Registry as a national reference for United States multiple myeloma patients
: Sikander Ailawadhi, և այլն
Հրապարակվել է: (2020-01-01) -
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
: Sundar Jagannath, և այլն
Հրապարակվել է: (2018-07-01) -
Lenalidomide-Associated ITP
: Christina I. Herold, և այլն
Հրապարակվել է: (2011-01-01)